You are here: Home » News-CM » Companies » News
Business Standard

Natco's partner Alvogen to market generic Oseltamivir phosphate power for oral suspension

Capital Market 

In US market

announced that its marketing partner Alvogen has received the final approval and is the first to market the generic equivalent to Oseltamivir phosphate, 6 mg/ ml powder for oral suspension in the United States. In December 2016, Alvogen launched the first generic equivalent to oseltamivir phosphate capsules in the United States.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, November 03 2017. 11:26 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU